Drug use and opioid substitution treatment for prisoners

被引:51
|
作者
Stoever, Heino [1 ]
Michels, Ingo Ilja [2 ]
机构
[1] Univ Appl Sci, Res Inst Addict, D-60318 Frankfurt, Germany
[2] Deutsch Gesell Tech Zusammenarbeit GTZ, Cent Asia Drug Act Programme CADAP European Union, Bishkek, Kyrgyzstan
关键词
METHADONE-MAINTENANCE TREATMENT; RANDOMIZED CONTROLLED-TRIAL; HEPATITIS-C; BUPRENORPHINE; TRANSMISSION; RISK; HIV; ATTITUDES; INJECTION;
D O I
10.1186/1477-7517-7-17
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Drug use is prevalent throughout prison populations, and, despite advances in drug treatment programmes for inmates, access to and the quality of these programmes remain substantially poorer than those available for non-incarcerated drug users. Because prisoners may be at greater risk for some of the harms associated with drug use, they deserve therapeutic modalities and attitudes that are at least equal to those available for drug users outside prison. This article discusses drug use by inmates and its associated harms. In addition, this article provides a survey of studies conducted in prisons of opioid substitution therapy (OST), a clinically effective and cost-effective drug treatment strategy. The findings from this overview indicate why treatment efforts for drug users in prison are often poorer than those available for drug users in the non-prison community and demonstrate how the implementation of OST programmes benefits not only prisoners but also prison staff and the community at large. Finally, the article outlines strategies that have been found effective for implementing OST in prisons and offers suggestions for applying these strategies more broadly.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Young adults' opioid use trajectories: From nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose
    Guarino, Honoria
    Mateu-Gelabert, Pedro
    Teubl, Jennifer
    Goodbody, Elizabeth
    ADDICTIVE BEHAVIORS, 2018, 86 : 118 - 123
  • [23] Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective
    Hall, Natasha Yvonne
    Le, Long
    Majmudar, Ishani
    Mihalopoulos, Cathrine
    DRUG AND ALCOHOL DEPENDENCE, 2021, 221
  • [24] Opioid agonist treatment and the process of injection drug use initiation
    Luisa Mittal, Maria
    Jain, Sonia
    Sun, Shelly
    DeBeck, Kora
    Milloy, M. J.
    Hayashi, Kanna
    Hadland, Scott E.
    Werb, Dan
    DRUG AND ALCOHOL DEPENDENCE, 2019, 197 : 354 - 360
  • [25] Substitution Treatment for Opioid Dependent in Focus
    Stoever, Heino
    SUCHTTHERAPIE, 2016, 17 (01) : 1 - U57
  • [26] Opium tincture for opioid substitution treatment
    Nikoo, M.
    Kianpoor, K.
    Nikoo, N.
    Javidanbardan, S.
    Kazemi, A.
    Choi, F.
    Vogel, M.
    Gholami, A.
    Tavakoli, S.
    Wong, J.
    Moazen-Zadeh, E.
    Givaki, R.
    Jazani, M.
    Mohammadian, F.
    Moghaddam, N. Markazi
    Schutz, C.
    Jang, K.
    Akhondzadeh, S.
    EUROPEAN PSYCHIATRY, 2021, 64 : S171 - S171
  • [27] Opioid substitution treatment programs in Slovenia
    Kastelic, Andrej
    Kostnapfel, Tatja
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2010, 79 (7-8): : 575 - 581
  • [28] Substitution treatment for opioid addicts in Germany
    Michels I.I.
    Stöver H.
    Gerlach R.
    Harm Reduction Journal, 4 (1)
  • [29] Contingency Management in Opioid Substitution Treatment
    Specka, M.
    Boening, A.
    Scherbaum, N.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2011, 79 (07) : 395 - 403
  • [30] WIDENING THE PERSPECTIVE ON OPIOID SUBSTITUTION TREATMENT
    Selin, Jani
    ADDICTION, 2017, 112 (08) : 1339 - 1340